Borel Anne-Laure, Boizel Robert, Faure Patrice, Barbe Geneviève, Boutonnat Jean, Sturm Nathalie, Seigneurin Daniel, Bricault Ivan, Caravel Jean-Pierre, Chaffanjon Philippe, Chabre Olivier
Endocrinology, CHU Albert Michallon and Université Joseph Fourier, 38043 Grenoble, France.
Eur J Endocrinol. 2008 May;158(5):691-8. doi: 10.1530/EJE-07-0749.
Measurement of thyroglobulin in the washout of lymph node (LN) fine needle aspirates is recommended in the follow-up of patients with differentiated thyroid cancer (DTC). The significance of low fine needle aspirates thyroglobin (FNATg) levels remains a question, which we addressed.
Prospective study comparing FNATg with FNA cytology. Exploration of 34 DTC patients (53 cervical LNs), 26 non-thyroidectomized patients with a thyroid-unrelated cervical mass (negative controls) and 13 with 21 thyroid nodules (positive controls). The 12 DTC patients (19 LNs) with a malignant FNA cytology and/or high FNATg level received LN surgery (11 patients) or I(131)-iodine treatment (1 patient) and the outcome measure was pathological or scintigraphic evidence of DTC LN metastasis.
All 26 negative controls showed FNATg <1 ng/FNA and all 21 positive controls showed high levels of FNATg (127-210,000 ng/FNA, median 38,000). Among DTC patients in 25 LNs with a benign FNA cytology, FNATg was undetectable in 24 and low in 1 (6 ng/FNA); in 19 LNs with a malignant FNA cytology, FNATg was high in 17 (80-140,000 ng/FNA, median 7174 ng/FNA) and low in 2 (6.6 and 7.1 ng/FNA), which proved to be low Tg immunostaining oncocytic DTC metastasis; in 9 LNs with a non-informative cytology, FNATg was undetectable in 8 but 11,825 ng/FNA in 1, which proved a DTC metastasis. Measurement of FNA albumin demonstrated that contamination of FNA by serum proteins was negligible.
Low FNATg levels can indicate a DTC metastasis. It cannot be related to clinically relevant levels of serum Tg.
在分化型甲状腺癌(DTC)患者的随访中,建议对淋巴结(LN)细针穿刺抽吸物洗脱液中的甲状腺球蛋白进行检测。细针穿刺抽吸物甲状腺球蛋白(FNATg)水平较低的意义仍不明确,我们对此进行了研究。
一项前瞻性研究,比较FNATg与细针穿刺活检细胞学检查结果。研究对象包括34例DTC患者(53个颈部淋巴结)、26例未行甲状腺切除术且患有与甲状腺无关的颈部肿块的患者(阴性对照)以及13例有21个甲状腺结节的患者(阳性对照)。12例细针穿刺活检细胞学检查为恶性和/或FNATg水平较高的DTC患者(19个淋巴结)接受了淋巴结手术(11例患者)或I(131)碘治疗(1例患者),结局指标为DTC淋巴结转移的病理或闪烁显像证据。
所有26例阴性对照的FNATg均<1 ng/细针穿刺抽吸物,所有21例阳性对照的FNATg水平均较高(127 - 210,000 ng/细针穿刺抽吸物,中位数为38,000)。在25个细针穿刺活检细胞学检查为良性的DTC患者的淋巴结中,24个淋巴结的FNATg检测不到,1个淋巴结的FNATg水平较低(6 ng/细针穿刺抽吸物);在19个细针穿刺活检细胞学检查为恶性的淋巴结中,17个淋巴结的FNATg水平较高(80 - 140,000 ng/细针穿刺抽吸物,中位数为7174 ng/细针穿刺抽吸物),2个淋巴结的FNATg水平较低(6.6和7.1 ng/细针穿刺抽吸物),这两个淋巴结经证实为低Tg免疫染色的嗜酸性DTC转移;在9个细针穿刺活检细胞学检查结果不明确的淋巴结中,8个淋巴结的FNATg检测不到,但1个淋巴结的FNATg为11,825 ng/细针穿刺抽吸物,该淋巴结经证实为DTC转移。细针穿刺抽吸物白蛋白检测表明,血清蛋白对细针穿刺抽吸物的污染可忽略不计。
低FNATg水平可能提示DTC转移。它与临床相关的血清Tg水平无关。